Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Incite 101`s..jldmt/ Fut?

RE: Incite 101`s..jldmt/ Fut?

posted on Aug 17, 2006 08:03AM

If I read it correctly, PTSC would only be able to show actual revenue received on financial statements. That makes sense. However, the IP as an ``asset`` is a tough one to value even if clearly stated as non-GAAP.

Does it translate that anyone in the Wall Street world could only ``value`` the company at the current level of revenue without counting any future deals? ...unless PTSC issued future guidence numbers (unlikely, IMO) to then be used Q over Q to prove accurarcy? Again, tough one to assign a value except in real time. A true ``What have you done lately?`` kinda speculation. I realized we are all speculating about value, but hopefully, PTSC`s company valuation will be an issue one day.

One possibility (WAG) would be through aquisition of a parts / finished goods company with a real and somewhat predictable revenue stream. This would give steady SG & A numbers for P & L statements so Wall Street could have some level of forward looking information.

All JIMO.

John

Share
New Message
Please login to post a reply